Table.
Clinical Characteristics of Lung Cancer Patients
| Patient | Age | Sex | Smoking history | Presenting symptoms | PS | Histology | Stage | Site of primary tumor | Others sites of disease | Treatment | Survival |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 63 | F | 80-pack year | Generally unwell, hyponatraemia | 2 | Small cell lung cancer | T4N2M1 extensive | Right middle lobe | Mediastinal nodes, pleura, pericardium, and liver | Carboplatin | Died 51 days |
| 2 | 76 | M | 40-pack year | Breathlessness hyponatraemia | 2 | Small cell lung cancer | T4N2M1 extensive | Right main bronchus | Mediastinal nodes, left adrenal gland, and liver | Carboplatin | Alive 71 days |
| 3 | 73 | M | 58-pack year | Weight loss, anorexia | 2 | Small cell lung cancer | T4N3M1 extensive | Left lower lobe | Mediastinal nodes, pleura, and left adrenal gland | Carboplatin | Died 115 days |
| 4 | 65 | F | 25-pack year | Breathlessness, cough, weight loss | 1 | Nonsmall cell lung cancer (adenocarcinoma) | T4N3M0 stage IIIB | Left lower lobe | Mediastinal nodes | Gemcitabine and carboplatin (sequential XRT) | Alive 108 days |
| 5 | 72 | M | 30-pack year | Cough | 0 | Nonsmall cell lung cancer (bronchioalveolar) | T2N0M1 stage IV | Right lower lobe | Multiple pulmonary nodules | Gemcitabine and carboplatin, erlotinib, XRT to spine | Died 330 days |
| Relapse after 1st-line treatment at 3 months with liver and bone metastases | |||||||||||
| 6 | 77 | M | 80-pack year | Interscapular back pain | 1 | Nonsmall cell lung cancer (squamous cell carcinoma) | T4N1M0 stage IIIB | Right upper lobe | No metastases at presentation | Gemcitabine and carboplatin (sequential XRT lung) | Died 210 days |
| Relapse after 1st-line treatment at 6 months with bone metastases |
F, female; M, male; PS, performance status; XRT, X-ray therapy.